Notably, endogenous oligodendrocyte differentiation has been observed until as late as 3 mo after CNS injuries [39], and this prolonged effort may provide a sufficiently wide therapeutic window that allows delayed IL-4 treatment to restore white matter and encourage long-term stroke recovery. The gene discussed is IL4; the disease is stroke disorder.